These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 35193525)

  • 1. Chemotherapy versus chemoradiotherapy for FIGO stages IB1 and IIA1 cervical squamous cancer patients with lymphovascular space invasion: a retrospective study.
    Zhang H; Yu R; Zhang L; Wang R; Xiao L
    BMC Cancer; 2022 Feb; 22(1):202. PubMed ID: 35193525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of adjuvant therapy after radical hysterectomy in intermediate-risk, early-stage cervical cancer.
    Cao L; Wen H; Feng Z; Han X; Zhu J; Wu X
    Int J Gynecol Cancer; 2021 Jan; 31(1):52-58. PubMed ID: 33303568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemotherapy versus radiotherapy for FIGO stages IB1 and IIA1 cervical carcinoma patients with postoperative isolated deep stromal invasion: a retrospective study.
    Li L; Song X; Liu R; Li N; Zhang Y; Cheng Y; Chao H; Wang L
    BMC Cancer; 2016 Jul; 16():403. PubMed ID: 27387204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathologic Factors of Cervical Adenocarcinoma Stages IB to IIB.
    Mabuchi Y; Yahata T; Kobayashi A; Tanizaki Y; Shiro M; Ota N; Yagi S; Minami S; Ino K
    Int J Gynecol Cancer; 2015 Nov; 25(9):1677-82. PubMed ID: 26495760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of the addition of concurrent chemotherapy to pelvic radiotherapy in surgically treated stage IB1-IIB cervical cancer patients with intermediate-risk or high-risk factors: a 13-year experience.
    Okazawa M; Mabuchi S; Isohashi F; Suzuki O; Yoshioka Y; Sasano T; Ohta Y; Kamiura S; Ogawa K; Kimura T
    Int J Gynecol Cancer; 2013 Mar; 23(3):567-75. PubMed ID: 23385284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Results of different postoperative adjuvant therapies for stage Ib-IIa cervical carcinoma with risk factors].
    Wen HW; Huang WP; Liu TY; Ma K; Tao X; Zhu LR; Liao QP
    Zhonghua Fu Chan Ke Za Zhi; 2013 Dec; 48(12):920-4. PubMed ID: 24495686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of lymph vascular space invasion on prognosis of patients with early-stage cervical squamous cell carcinoma.
    Yan M; Zhang YN; He JH; Sun JR; Sun XM
    Chin J Cancer; 2010 Apr; 29(4):425-30. PubMed ID: 20346220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Analysis of effects and postoperative clinicopathological prognosis factors of neoadjuvant chemotherapy in patients with stage Ⅰb2 and Ⅱa2 squamous cell carcinoma of the cervix].
    An JS; Zhao YX; Song Y; Li N; Huang MN; Li XG; Li B; Zhang R; Wu LY
    Zhonghua Fu Chan Ke Za Zhi; 2019 Oct; 54(10):673-679. PubMed ID: 31648443
    [No Abstract]   [Full Text] [Related]  

  • 9. Lymphovascular and perineural invasion in the parametria: a prognostic factor for early-stage cervical cancer.
    Memarzadeh S; Natarajan S; Dandade DP; Ostrzega N; Saber PA; Busuttil A; Lentz SE; Berek JS
    Obstet Gynecol; 2003 Sep; 102(3):612-9. PubMed ID: 12962952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of lymphovascular space invasion in early-stage cervical cancer.
    Weyl A; Illac C; Lusque A; Leray H; Vaysse C; Martinez A; Chantalat E; Motton S
    Int J Gynecol Cancer; 2020 Oct; 30(10):1493-1499. PubMed ID: 32565486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical analysis of the recurrence of early stage bulky cervical carcinoma].
    Hu JL; Wu LY; Li XG; Zhang R; Li N; Yao HW
    Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):378-81. PubMed ID: 22883461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prognostic analysis of stage Ⅰb2 andⅡa2 cervical squamous cancer without high risk factors treated with neo-adjuvant chemotherapy and radical hysterectomy].
    Li PP; Li B; Wang YT; Liu SH; Zhang YN; Zhang R; Bai P; Li XG; Wu LY
    Zhonghua Fu Chan Ke Za Zhi; 2018 Apr; 53(4):248-256. PubMed ID: 29747270
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical significance of serum squamous cell carcinoma antigen in patients with early cervical squamous cell carcinoma].
    Li D; Xu XX; Yan DD; Yuan SH; Lou HM
    Zhonghua Zhong Liu Za Zhi; 2019 May; 41(5):357-362. PubMed ID: 31137169
    [No Abstract]   [Full Text] [Related]  

  • 14. Tailoring Pelvic Lymphadenectomy for Patients with Stage IA2, IB1, and IIA1 Uterine Cervical Cancer.
    Zhou J; Ran J; He ZY; Quan S; Chen QH; Wu SG; Sun JY
    J Cancer; 2015; 6(4):377-81. PubMed ID: 25767608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors predicting parametrial invasion in patients with early-stage cervical carcinomas.
    Hsu HC; Tai YJ; Chen YL; Chiang YC; Chen CA; Cheng WF
    PLoS One; 2018; 13(10):e0204950. PubMed ID: 30335786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Locoregional spread and survival of stage IIA1 versus stage IIA2 cervical cancer.
    Hongladaromp W; Tantipalakorn C; Charoenkwan K; Srisomboon J
    Asian Pac J Cancer Prev; 2014; 15(2):887-90. PubMed ID: 24568513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of the effect of adjuvant radiotherapy on outcomes and complications after radical hysterectomy in FIGO stage IB1 cervical cancer patients with intermediate risk factors (GOTIC Study).
    Nakamura K; Kitahara Y; Satoh T; Takei Y; Takano M; Nagao S; Sekiguchi I; Suzuki M
    World J Surg Oncol; 2016 Jun; 14(1):173. PubMed ID: 27356862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histopathological findings in postoperative specimens in cervical cancer patients with stages IB2-IVA after neoadjuvant chemotherapy and preoperative plus postoperative radiotherapy.
    Kornovski Y; Gorchev G
    J BUON; 2007; 12(1):57-63. PubMed ID: 17436403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic model in patients with early-stage squamous cell carcinoma of the uterine cervix: a combination of invasive margin pathological characteristics and lymphovascular space invasion.
    Khunamornpong S; Lekawanvijit S; Settakorn J; Sukpan K; Suprasert P; Siriaunkgul S
    Asian Pac J Cancer Prev; 2013; 14(11):6935-40. PubMed ID: 24377504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic factors affecting the outcome of early cervical cancer treated with radical hysterectomy and post-operative adjuvant therapy.
    Liu MT; Hsu JC; Liu WS; Wang AY; Huang WT; Chang TH; Pi CP; Huang CY; Huang CC; Chou PH; Chen TH
    Eur J Cancer Care (Engl); 2008 Mar; 17(2):174-81. PubMed ID: 18302655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.